| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1742-1241.2009.02220.X |
| P698 | PubMed publication ID | 20716150 |
| P2093 | author name string | Y M Smulders | |
| B A C Dijkmans | |||
| N Sattar | |||
| A E Voskuyl | |||
| M J L Peters | |||
| M T Nurmohamed | |||
| P2860 | cites work | Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 |
| P433 | issue | 10 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 1440-1443 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | International Journal of Clinical Practice | Q15758177 |
| P1476 | title | The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better | |
| P478 | volume | 64 |
| Q43826908 | A randomized controlled trial of a cognitive behavioural patient education intervention vs a traditional information leaflet to address the cardiovascular aspects of rheumatoid disease. |
| Q50953966 | Analysis and modelling of cholesterol and high-density lipoprotein cholesterol changes across the range of C-reactive protein levels in clinical practice as an aid to better understanding of inflammation-lipid interactions. |
| Q88917533 | Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis |
| Q58609925 | Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis |
| Q38124279 | Cardiovascular risk in the rheumatic disease patient undergoing orthopedic surgery |
| Q38115132 | Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm |
| Q38745362 | Effects of synthetic and biological disease modifying antirheumatic drugs on lipid and lipoprotein parameters in patients with rheumatoid arthritis |
| Q46170190 | Evaluating the contribution of gut microbiome to the variance of porcine serum glucose and lipid concentration |
| Q36245981 | High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study |
| Q46027578 | Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis. |
| Q48508157 | Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study |
| Q38026796 | Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies |
| Q34684331 | Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease |
| Q53491083 | Reply: To PMID 25504899. |
| Q50192090 | The Role of Statins in Disease Modification and Cardiovascular Risk in Rheumatoid Arthritis |
| Q37533298 | Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment |
| Q26822912 | Unresolved questions in rheumatology: motion for debate: the data support evidence-based management recommendations for cardiovascular disease in rheumatoid arthritis |
| Q36098818 | Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis |
Search more.